MAGED2 mRNA overexpression leads to tumor growth in hepatocellular carcinoma, according to Kanda and colleagues, and thus may serve as a prognosis indicator after curative resection as well as a possible therapeutic target in hepatocellular carcinoma [16]. This evidence concerns the gene MAGED2 and hepatocellular carcinoma.